Hypothesis

If aging arises from declining selection pressure rather than an adaptive death program, then genes that sit at the intersection of high early‑life essentiality and relaxed late‑life constraint will form topological hubs in the human interactome. These hubs should show (i) strong purifying selection on their early‑life interacting partners, (ii) weaker conservation of late‑life‑specific interactions, and (iii) a measurable fitness trade‑off: perturbing the late‑life‑specific edges extends lifespan without reducing early‑life reproductive output.

Mechanistic reasoning

1. Evolutionary expectation – Under mutation accumulation and antagonistic pleiotropy, selection removes deleterious alleles that affect fitness before reproduction, but allows late‑acting deleterious alleles to persist. Genes whose products are required for growth, development, or early‑life reproduction become highly connected “date hubs” that coordinate multiple pathways. Late‑life‑specific interactions, being under relaxed constraint, accumulate more sequence divergence and are more likely to be condition‑dependent (e.g., stress‑responsive).
2. Network prediction – A graph‑neural‑network (GNN) trained on experimentally validated aging interventions from the NIH/NIA Interventions Testing Program NIH/NIA ITP should learn to distinguish two classes of nodes:
   • Programmed‑like: densely connected modules with uniform high conservation across all ages.
   • *N

Hypothesis

VSMC metabolic reprogramming driven by HIF‑1α–PDK1 signaling suppresses tropoelastin (ELN) transcription and pushes cells toward an osteogenic phenotype, thereby linking arterial stiffness to active calcification.

Mechanistic Rationale

Recent work shows that VSMC phenotypic switching and inflammation are central to stiffness [1][2]. Yet the drop in tropoelastin synthesis remains poorly linked to these cellular states [3]. We propose that sustained HIF‑1α activation—common in atherosclerotic plaques under oscillatory shear and hypoxia—up‑regulates pyruvate dehydrogenase kinase 1 (PDK1). PDK1 phosphorylates and inhibits pyruvate dehydrogenase, shunting pyruvate away from mitochondria and toward lactate production. This metabolic shift lowers acetyl‑CoA availability for histone acetylation at the ELN promoter, reducing tropoelastin transcription. Simultaneously, HIF‑1α directly binds osteogenic promoters such as RUNX2, favoring a calcifying VSMC state. The combined effect yields stiff, calcified arteries without requiring elastin fragmentation as a primary cause.

Testable Predictions

1. In human carotid plaques, high HIF‑1α and PDK1 expression will correlate with low ELN mRNA and high RUNX2 levels at the single‑cell level.
2. Pharmacologic inhibition of PDK1 (e.g., with dichloroacetate) in ex‑vivo plaque cultures will increase ELN transcription and decrease alkaline phosphatase activity, a marker of osteogenic VSMCs.
3. Genetic knockdown of HIF‑1α in VSMCs of atherosclerotic mice will preserve elastin content and reduce calcification despite unchanged

Hypothesis

Senescent cells in the aging cochlea exhibit a temporal switch in their secretory profile: early‑stage senescence releases a SASP enriched in trophic and angiogenic factors that support spiral ganglion neuron (SGN) survival and stria vascularis function, whereas chronic senescence shifts the SASP toward pro‑inflammatory mediators that exacerbate hair cell loss, SGN degeneration, and endocochlear potential decline. Consequently, blunt senolytic ablation removes both detrimental and beneficial secretions, potentially worsening hearing loss if administered before the pathogenic switch.

Mechanistic Rationale

• Early protective SASP: In vitro oxidative stress models show that transient p21‑positive senescent fibrocyte‑like cells upregulate IGF‑1, VEGF, and TGF‑β1, which promote SGN neurite outgrowth and maintain potassium recycling in the stria vascularis (2). These factors parallel the regenerative SASP observed in other tissues where senescent cells aid wound healing.
• Transition to pathogenic SASP: Persistent DNA damage and mitochondrial ROS amplify NF‑κB signaling, converting the secretome to IL‑1α, IL‑6, CCL2, and MMP‑9. This inflammaging SASP recruits neutrophils and macrophages, driving the cytokine milieu linked to SGN apoptosis and stria atrophy (3).
• Evidence of temporal dichotomy: Studies reporting senescent cell accumulation correlating with hearing loss primarily examined end‑point aged tissues, capturing the late pathogenic stag

Hypothesis

We propose that intracellular NAD+ concentration acts as a metabolic gatekeeper that determines whether a cell can successfully undergo OSK‑driven partial reprogramming. When NAD+ falls below a tissue‑specific threshold, sirtuin activity and PARP‑mediated DNA repair become limiting, causing the chromatin landscape to resist the epigenetic resetting imposed by OSK factors. Consequently, reprogramming efficiency—and the ensuing functional benefits—scale with NAD+ levels, and boosting NAD+ prior to or during OSK pulses should lower the effective dose and shorten the exposure time needed to achieve a youthful methylome.

Mechanistic Rationale

• Sirtuin‑dependent chromatin remodeling: SIRT1 and SIRT6 deacetylate histones and transcription factors, facilitating the opening of repressed loci that OSK factors target. NAD+‑dependent sirtuin activity has been shown to enhance the accessibility of pluripotency‑associated promoters in fibroblasts 1.
• PARP competition for NAD+: In aged cells, DNA damage elevates PARP consumption, sequestering NAD+ away from sirtuins. This shifts the NAD+ budget toward repair at the expense of epigenetic modulation, creating a bistable state where high PARP activity locks chromatin in an aged configuration despite OSK presence 2.
• **Metabolic sen

Hypothesis

Corneal mechanical sensitivity, when adjusted for tear‑borne neuroinflammatory signals, serves as a more sensitive readout of systemic biological age than sensitivity alone.

Rationale

• Aging reduces corneal nerve density and raises mechanical detection thresholds, reflecting structural changes such as collagen glycation and keratocyte senescence[1][2][3][4].
• However, in inflammatory ocular states (e.g., dry eye) the cornea becomes hypersensitive despite ongoing structural degeneration, indicating a uncoupling of nerve function from matrix integrity[5].
• This uncoupling parallels systemic inflammaging: elevated pro‑inflammatory cytokines in tears (IL‑6, TNF‑α, IL‑1β) correlate with leukocyte telomere attrition and clonal hematopoiesis[6][7].
• Mitochondrial dysfunction in circulating leukocytes predicts both increased pain perception and reduced vagal tone, linking cellular energy status to neuro‑immune communication[8].

Novel Mechanism

We propose that senescent keratocytes release a senescence‑associated secretory phenotype (SASP) that modulates corneal nerve growth factor (NGF) and brain‑derived neurotrophic factor (BDNF) levels. Simultaneously, tear cytokines reflect the systemic SASP spillover, creating a composite signal where:

• High threshold (hyposensitivity) indicates predominant matrix stiffening and nerve loss.
• Low threshold (hypersensitivity) amid high tear cytokines signals SASP‑driven nerve sensitization despite matrix decay. Thus, the ratio of threshold to tear inflammatory load captures the balance between structural aging a

Hypothesis

Aging‑associated suppression of tropoelastin in large arteries is an adaptive program that lowers maximal cardiac output and basal metabolic rate in post‑reproductive individuals, thereby reducing their consumption of shared resources and increasing the survival prospects of younger kin.

Mechanistic Rationale

• Tropoelastin mRNA remains transcriptionally active but is silenced post‑transcriptionally in aging lungs and vasculature pubmed.ncbi.nlm.nih.gov/7797468/.
• TGF‑β drives elastin transcription while TNF‑α promotes its degradation, showing active control frontiersin.org/articles/10.3389/fcell.2021.596702/full.
• Epigenetic silencers (miR‑29, Polycomb complexes) and conserved pathways (sirtuins, mTOR) reinforce this downregulation pmc.ncbi.nlm.nih.gov/articles/PMC6248882/.
• Reduced arterial compliance raises systolic load, limiting stroke volume and maximal O₂ delivery during exertion.
• Lower cardiac output decreases ATP turnover and ROS production, curbing tissue wear without requiring new damage‑repair investment.
• From an evolutionary perspective, diminished resource use by older individuals lessens competition for food, oxygen, and space, directly benefiting offspring and grand‑offspring survival—an extension of the disposable soma logic to a kin‑selected trait.

Novel Prediction

Restoring tropoelastin expression in the vasculature of age

Hypothesis

Elevating intracellular NAD+ levels enhances the formation of ordered, Hsp42‑like protein deposits that act as a protective, phase‑separated reservoir for misfolded proteins in aging mammalian cells.

Mechanistic Rationale

In yeast, Hsp42 drives the asymmetric sequestration of aggregated proteins into a single, stable deposit that retains chaperone accessibility and stress resistance 1. This process depends on liquid‑liquid phase separation, which is tuned by post‑translational modifications such as phosphorylation and arginine methylation 2 3. NAD+‑dependent sirtuins (especially SIRT2) deacetylate lysine residues on small heat‑shock proteins (e.g., HspB5/αB‑crystallin), promoting their oligomerization into amyloid‑like structures that retain dynamic exchange. We propose that NAD+ boost mimics the yeast Hsp42 pathway by activating SIRT2, thereby shifting the equilibrium from disordered aggregates to ordered deposits that safely sequester toxic species.

Testable Predictions

• NAD+ supplementation (NR or NMN) increases the fraction of cells containing Thioflavin‑T‑positive, FRAP‑slow deposits compared with untreated aged controls.
• SIRT2 inhibition or knock‑down abolishes the NAD+‑induced increase in ordered deposit formation without changing total aggregate load.
• Cells with elevated NAD+ show faster clearance of an acute proteotoxic stressor (e.g., heat

Hypothesis

Intermittent high-dose dosing of quercetin phytosome produces short-lived lysosomal ROS bursts in senescent adipocytes that exceed the threshold for apoptosis induction, whereas continuous lower-dose isoquercetin fails to achieve this peak despite higher overall AUC.

Rationale

• Quercetin’s senolytic activity in vitro requires 6‑20 μM to trigger mitochondrial permeabilization and caspase‑3 activation【4】.
• Plasma concentrations after phytosome dosing remain in the low‑nanomolar range, but preclinical work shows flavonoid accumulation in lysosomes of hepatocytes and adipocytes, reaching micromolar levels locally【5】.
• The lipid‑based phytosome formulation promotes lymphatic uptake and preferential partitioning into adipose tissue, creating a depot that can release quercetin in pulses upon lipolysis or adipocyte turnover.
• Lysosomal quercetin can redox‑cycle with iron, generating hydroxyl radicals via Fenton chemistry; this ROS burst is sufficient to oxidize cardiolipin and release cytochrome c, activating the intrinsic apoptotic pathway independently of NLRP3 inflammasome signaling.
• Isoquercetin, being more hydrophilic, is absorbed faster but cleared quicker, yielding a flatter plasma curve that does not generate the transient intracellular spikes needed for lysosomal ROS generation.

Testable Predictions

1. In obese human volunteers, a single 500 mg dose of quercetin phytosome will produce a transient (≤2 h) increase in lysosomal quercetin concentration ≥10 μM in subcutaneous adipose biopsies, measured by LC‑MS after subcellular fractionation, while

Hypothesis

Combined pharmacological recoupling of eNOS and blockade of ICAM-1-mediated leukocyte adhesion will suppress the senescence-associated secretory phenotype (SASP) in endothelial cells more effectively than either intervention alone, breaking the ROS–NF-κB–ICAM-1 positive feedback loop.

Rationale

Endothelial senescence generates a self‑amplifying circuit: eNOS uncoupling produces superoxide that activates NF-κB, driving ICAM-1 transcription; ICAM-1‑dependent leukocyte adhesion adds extracellular ROS that further oxidizes BH4 and sustains eNOS uncoupling [1][2][3]. SASP cytokines such as IL-6 and IL-8 are upregulated downstream of NF-κB and MAPK signaling [4]. While BH4 supplementation restores eNOS coupling and anti‑ICAM-1 antibodies reduce leukocyte recruitment, each approach leaves one arm of the loop intact, allowing residual signaling to maintain SASP. Simultaneously targeting both nodes should collapse the loop, lower mitochondrial and NADPH oxidase ROS, diminish NF-κB nuclear translocation, and consequently attenuate SASP factor secretion.

Experimental Design

In vitro: Human umbilical vein endothelial cells (HUVECs) will be induced to senesce via low‑dose TNF‑α (10 ng/mL) for 5 days [3]. Four treatment groups will be tested: (1) vehicle, (2) BH4 (10 µM) to recouple eNOS, (3) anti‑ICAM‑1 blocking antibody (5 µg/mL), (4) BH4 + anti‑ICAM‑1. After 24 h of treatment, we will measure: superoxide production (DHE fluorescence), eNOS coupling (nitrate/nitrite ratio), NF-κB p65 nuclear translocation (immunofluorescence), ICAM-1 surface expression (flow c

Mechanistic Basis

We propose that the pulsatile secretion of gonadotropin‑releasing hormone (GnRH) from the hypothalamus functions as a master timer that coordinates the circadian‑hypothalamic axis described in recent work. GnRH pulse frequency sets the downstream release of pituitary hormones—growth hormone (GH), luteinizing hormone (LH), and thyroid‑stimulating hormone (TSH)—which in turn entrain the suprachiasmatic nucleus (SCN) and peripheral clocks through hormone‑dependent signaling pathways (e.g., GH‑STAT5, LH‑cAMP). Altered GnRH pulsatility with advancing age reduces GH/IGF‑1 signaling, diminishes SIRT1 activity, and weakens the molecular clock, thereby increasing oxidative stress and DNA damage [1,2]. Simultaneously, low‑frequency GnRH pulses disinhibit NF‑κB signaling in hypothalamic microglia, fostering a chronic inflammatory state that suppresses GnRH neurons themselves—a positive feedback loop [3]. This dual influence places GnRH pulsatility upstream of both circadian disruption and hypothalamic inflammation, positioning it as a candidate controller of the six hallmarks of aging.

Testable Predictions

1. Restoring youthful GnRH pulse frequency in aged mice will re‑synchronize central and peripheral circadian rhythms, reduce hypothalamic NF‑κB activity, improve DNA‑repair markers, and extend median lifespan.
2. Inducing irregul

Hypothesis

Age‑associated accumulation of mitochondrial DNA (mtDNA) lesions in endothelial cells triggers a systemic pro‑thrombotic state by packaging damaged mtDNA into extracellular vesicles (EVs) that activate the cytosolic DNA sensor cGAS‑STING pathway in circulating monocytes and platelets, leading to tissue factor (TF) expression and elevated Factor VIII/VWF levels.

Mechanistic Model

1. mtDNA damage – With age, polymerase γ errors and deficient mitophagy increase heteroplasmic mtDNA deletions and point mutations, raising mitochondrial ROS and releasing oxidized mtDNA fragments into the cytosol 2.
2. EV loading – Stressed endothelial cells sort oxidized mtDNA into shedding microvesicles and exosomes via ESCRT‑dependent pathways, a process amplified by disrupted mitochondrial‑ER calcium signaling.
3. EV‑mediated cGAS‑STING activation – Circulating EVs deliver mtDNA to monocytes and platelets, where cytosolic cGAS senses the DNA, synthesizes 2′‑3′‑cGAMP, and drives STING‑dependent IRF3/NF‑κB signaling.
4. Inflammatory‑thrombotic output – STING signaling upregulates NF‑κB‑dependent TF, IL‑6, and P‑selectin, while IRF3 promotes type‑I interferon that further stimulates endothelial VWF release.
5. Systemic effect – EV‑borne signaling creates a feed‑forward loop: endothelial activation releases more EVs, sustaining elevated plasma TF activity, FVIII, and VWF, which together raise thrombotic risk 4.

Testable Predictions

• Prediction 1: Plasm

Hypothesis

The primary driver of mitochondrial contribution to cellular senescence is the release of damaged mitochondrial DNA (mtDNA) into the cytosol, where it activates the cGAS‑STING innate immune pathway, rather than the accumulation of mtDNA point mutations per se. This posits that interventions preventing mtDNA efflux or blocking cGAS‑STING signaling will reduce senescent cell burden and SASP even when mtDNA heteroplasmy remains high.

Mechanistic Rationale

1. mtDNA as a DAMP – Oxidative stress causes mitochondrial outer membrane permeabilization, allowing mtDNA fragments to escape into the cytoplasm. Once in the cytosol, mtDNA binds cGAS, producing 2’‑3’‑cGAMP and stimulating STING‑dependent NF‑κB and IRF3 signaling, which directly promotes the senescence‑associated secretory phenotype (SASP).

2. Dysfunction vs. Mutation – Studies show that mitochondrial dysfunction, not heteroplasmy load, correlates with ROS‑induced JNK activation and chromatin fragmentation. However, heteroplasmy does not always predict respiratory deficiency, suggesting that the mutagenic load is a poor functional readout. The missing link is the physical release of mtDNA, which can occur irrespective of mutation load when mitochondria are stressed.

3. Senolytic Sensitivity – Senescent cells that survive navitoclax exhibit heightened mitophagy, clearing damaged mitochondria more efficiently. If mitophagy removes mitochondria before they rupture, less mtDNA is released, explaining why boosting mitophagy confers senolytic resistance. Conversely, inhibiting mtDNA release should

Hypothesis

Estrogen loss in perimenopausal fibroblasts shifts chondroitin sulfate sulfation from the 6‑O‑ to the 4‑O‑position, and the altered GAG motif is packaged into exosomes that circulate as a predictive signature of impending dermal fibrosis.

Mechanistic Basis

Estrogen receptor α (ERα) directly binds promoter regions of the chondroitin‑6‑sulfotransferase (CHST3) gene, sustaining its expression in pre‑menopausal fibroblasts [GlycoAgeTest]. When estradiol declines, ERα activity falls, CHST3 transcription drops while the 4‑O‑sulfotransferase (CHST11) is derepressed via loss of ER‑mediated repression [Developmental GAG regulation]. The resulting CS‑4S enrichment increases electrostatic binding to collagen fibrils, promoting fibrillar alignment and matrix stiffening [ECM structural memory]. Stiff matrices activate fibroblast mechanotransduction (YAP/TAZ), which further upregulates CHST11, creating a feed‑forward loop. Altered CS‑4S chains are sorted into exosomes through interaction with syntenin‑ALIX cargo adapters, yielding EV‑borne GAG profiles that mirror the dermal ECM state.

Testable Predictions

1. In skin biopsies from women aged 40‑55, CS‑4S/CS‑6S ratios will rise sharply after the onset of menopause and correlate with serum estradiol levels (inverse relationship).
2. Exosomes isolated from peripheral blood of the same cohort will show a matching increase in CS‑4S‑containing chondroitin su

Hypothesis

Combining intermittent dasatinib+quercetin (D+Q) dosing with early time‑restricted eating (eTRE) creates a circadian‑gated autophagic surge that selectively targets senescent cells for clearance, thereby lowering SASP burden and improving tissue function more than either intervention alone.

Mechanistic Rationale

Senolytics induce apoptosis in senescent cells by disrupting SCAP–NET pathways, but many senescent cells resist death due to elevated anti‑apoptotic Bcl‑2 family members. eTRE, by restricting food intake to a 6‑hour window aligned with the active phase, amplifies hepatic SIRT1 activity and drives a robust autophagic flux marked by LC3‑II accumulation and p62 degradation. Autophagy can degrade mitochondrial antigens and lysosomal regulators that sustain senescent cell survival, effectively lowering the threshold for D+Q‑induced apoptosis. Moreover, the circadian clock component REV‑ERBα, upregulated during the fasting window, directly represses mTORC1 signaling, synergizing with D+Q‑mediated transient mTOR inhibition observed after senolytic exposure. This dual hit—autophagy‑mediated sensitisation plus mTOR suppression—should produce synthetic lethality specifically in cells exhibiting high p16^INK4a^ and SA‑β‑Gal activity, while sparing proliferating progenitors that rely on basal mTOR for growth.

Testable Predictions

1. Participants receiving D+Q plus eTRE will show a greater reduction in circulating p16^INK4a^‑positive extracellular vesicles compared to D+Q alone or eTRE alone after four weeks.
2. The combination will produce a larger decl

Hypothesis

Rapamycin extends lifespan by mimicking nutrient scarcity, but this impersonation leaves the underlying epigenetic noise and heterogeneity of aged cells unchanged, preserving a molecular 'memory' of prior damage.

Mechanistic Basis

While mTORC1 inhibition activates autophagy and suppresses SASP, it does not engage the chromatin remodelers that drive epigenetic resetting during true rejuvenation (e.g., OSK-mediated partial reprogramming). Rapamycin‑induced low‑energy signaling favors histone deacetylation via SIRT1 activation, leading to a compact but static heterochromatin that masks transcription of senescence genes without erasing age‑associated methylation drift or increasing nucleosome turnover. Consequently, the mean epigenetic age shifts downward, yet cell‑to‑cell variability and entropy remain high, reflecting persistent damage that rapamycin merely hides.

Predictions & Experimental Design

1. Epigenetic entropy will not decrease – Single‑cell methylome sequencing of liver from old mice treated with rapamycin for 3 months will show no reduction in Shannon entropy of CpG methylation compared to untreated aged controls, whereas partial reprogramming will lower entropy (1).
2. Transient heterochromatin marks increase – Rapamycin will elevate H3K9me3 and H3K27me3 levels globally, detectable by CUT&Tag, without a concomitant rise in H3K4me1 at enhancers that characterizes active chromatin remodeling (2).
3. Noise‑associated transcripts persist – RNA‑seq w

Hypothesis

Chronic NAD+ decline in aging beta cells reduces SIRT1 deacetylase activity, which alters the phosphorylation state of selective autophagy receptors (FAM134B for ER‑phagy, OPTN/Ndp52 for aggrephagy). This shift re‑programs the autophagy triage hierarchy, diverting limited autophagic capacity from ER membrane turnover toward clearance of toxic IAPP oligomers. The resulting ER expansion exacerbates proteotoxic stress, creating a vicious cycle that accelerates beta‑cell failure.

Mechanistic Basis

• SIRT1 directly deacetylates FAM134B at lysine residues, promoting its interaction with LC3 and efficient ER‑phagy [4]; acetylation blocks this interaction.
• SIRT1 also deacetylates TBK1, enhancing its ability to phosphorylate OPTN and Ndp52, thereby stimulating aggrephagy [3].
• In aged islets, NAD+ levels fall ~40 % [5], leading to hyper‑acetylated FAM134B (reduced ER‑phagy) and hypo‑acetylated TBK1 (increased aggrephagy).
• Consequently, ER expands (ER‑phagy insufficiency) while IAPP oligomer clearance rises temporarily, but the ER stress from membrane overload overwhelms the benefit, driving pro‑hIAPP dimer accumulation and cell death [1].

Testable Predictions

1. Pharmacological NAD+ restoration (e.g., NR or NMN) will increase SIRT1 activity, decrease FAM134B acetylation, and restore ER‑phagy flux without altering total autophagosome number.
2. Beta‑cell–specific SI

We hypothesize that autophagic flux during fasting is primarily driven by intracellular β‑hydroxybutyrate (BHB) concentration modulating lysosomal V‑ATPase activity, rather than by elapsed fasting time per se.

Mechanism

When hepatic glycogen falls (~12 h), adipose lipolysis releases free fatty acids that are oxidized to ketone bodies, chiefly BHB. Rising BHB binds to the lysosomal‑surface GPR109A receptor, triggering a cAMP‑PKA cascade that phosphorylates the V‑ATPase subunit ATP6V0D1, increasing proton pumping and luminal acidity. Acidic lysosomes enhance cathepsin activity and promote autophagosome‑lysosome fusion, completing autophagic flux. This pathway can be activated irrespective of total fasting duration if BHB reaches a threshold (~0.5 mM) that is achievable earlier in individuals with high basal lipolysis or low insulin sensitivity. It's important to note that this doesn't replace the metabolic switch at ~12 h; it simply positions autophagy as a downstream response to ketone signaling.

Prediction

If lysosomal acidification is the gatekeeper, then:

• Pharmacological inhibition of V‑ATPase (e.g., with bafilomycin A1) will abolish the LC3B‑II increase seen after 16 h fasting even when BHB is high.
• Exogenous BHB infusion (raising plasma BHB to 0.8 mM) will rescue autophagic flux in 12‑hour fasted subjects, restoring LC3B‑II turnover to levels comparable with 24‑hour fasting.
• Individuals with a genetic variant that reduces GPR109A expression will require longer fasting periods to achieve the same autophagic response, independent of glycogen status.

Expe

Hypothesis

Aging is maintained by an active germline‑soma signaling program that limits somatic mutation accumulation to protect germline integrity, rather than being a mere byproduct of declining selection.

Mechanistic Basis

• In many taxa, germ cells remain connected to somatic tissue via stable intercellular bridges (ring canals in Drosophila, germline‑soma junctions in C. elegans) that allow cytoplasmic exchange.
• These bridges permit the transfer of DNA‑damage signals, reactive oxygen species, and extracellular vesicles that can carry somatic mutations back to the germ line.
• We propose a conserved surveillance module: the Gap Junction‑Innexin/INX‑2‑dependent somatic‑to‑germline signal (SG‑S) activates the FOXO‑dependent stress response in somatic cells, driving a senescence program that reduces cellular proliferation and increases apoptosis, thereby lowering the flux of mutant genomes toward the germ line.
• This module is under positive selection because it reduces the mutational load transmitted to offspring, offsetting the cost of reduced somatic maintenance.

Novel Mechanistic Insight

The SG‑S pathway couples somatic senescence to germline genome fidelity through a mutational‑sensing checkpoint that monitors the frequency of transposon excision events in somatic extracellular vesicles; when vesicular transposon load exceeds a threshold, the signal amplifies FOXO activity, accelerating aging.

Testable Predictions

1. Reducing SG‑S signaling (e.g., innexin‑2 knock‑down) will extend somatic lifespan but increase the mutation rat

Hypothesis

Age‑related decline of Lactonifactor longoviformis reduces equol production from dietary daidzein, diminishing ERβ‑mediated anti‑inflammatory signaling and accelerating inflammaging.

Mechanistic rationale

While L. longoviformis is known for lignan dehydrogenation, its genome harbors flavin‑dependent reductase domains homologous to those in validated equol‑producing strains (e.g., Slackia isoflavoniconvertens). Age‑associated shifts in bile acid pools—particularly increased secondary bile acids such as deoxycholic acid—have been shown to suppress Clostridiaceae metabolic activity Bile acid inhibition. We hypothesize that these bile acid changes selectively inhibit the cryptic daidzein‑reducing pathway in L. longoviformis, lowering equol synthesis in older hosts.

Equol acts as a selective estrogen receptor β (ERβ) agonist, dampening NF‑κB driven cytokine production ERβ anti‑inflammatory. Reduced equol therefore removes a microbial checkpoint on intestinal and systemic inflammation, contributing to the well‑documented decline in tryptophan‑indole metabolism Tryptophan decline and the rise of inflammaging observed after age 34‑54.

Testable predictions

1. Abundance correlation – Quantitative PCR targeting the L. longoviformis 16S rRNA gene will show a significant negative correlation with host age (r < ‑0.4, p < 0.01) across cohorts aged 20‑80.
2. **